Active — Not RecruitingNot Applicable

Nurse AMIE (Addressing Malignancies in Individuals Everyday)

United States344 participantsStarted 2022-05-03

Plain-language summary

Nurse AMIE 3.0 is testing the effectiveness of an electronic symptom management system on overall survival in people with stage 3 and 4 cancer who live in rural areas.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient receiving care for their cancer
✓. Age: 18+ years of age
✓. Has stage 3 or 4 cancer, or an unstaged cancer that is considered 'advanced' (greater than stage 2) by their treating oncologist
✓. Must be within six months of initiation of pharmacologic or radiation treatment, for curative or palliative purposes, from a medical or radiation oncologist
✓. Clinician-rated ECOG function of 0-3
✓. Lives in a county with RUCC code 4 - 9 and/or zip code with RUCA code 4-10
✓. Has access to personal device capable of receiving telephone calls for study facilitator check-ins
✓. Fluent in written and spoken English

Exclusion criteria

✕. Patients with medical or psychiatric conditions documented in the medical record (beyond cancer, its treatments, and its symptoms) that would impair our ability to test study hypotheses (e.g. psychotic disorders, dementia, inability to give informed consent, or follow study instructions).
✕. Patients who are participating in any other supportive care or behavioral intervention studies.
✕. Non-English speaking patients will be excluded, as they represent less than 2% of the population targeted.

What they're measuring

Survival

Timeframe: through study completion, an average of two years

Trial details

NCT IDNCT05221606

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-03

View on ClinicalTrials.gov More Cancer trials